Increased incidence of QT interval prolongation in a population receiving lower doses of methadone maintenance therapy

Addiction

Volumn 107, Issue 6, 2012, Pages 1132-1139

  Roy, Andrew K ^a   Mccarthy, Catherine ^b   Kiernan, Gareth ^a   Mcgorrian, Catherine ^a   Keenan, Eamon ^b   Mahon, Niall G ^a   Sweeney, Brion ^a,b  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^b Drug Treatment Centre Board   (Ireland)

Author keywords

Arrhythmia; Cardiac safety; Cocaine; Drug induced long QT interval; Electrocardiogram; Lower dose methadone; Methadone; QT interval; Torsade de Pointes

Indexed keywords

METHADONE; NARCOTIC AGENT;

ADULT; ARTICLE; CHEMICALLY INDUCED DISORDER; CROSS-SECTIONAL STUDY; DOSE RESPONSE; ELECTROCARDIOGRAPHY; FEMALE; HUMAN; LONG QT SYNDROME; MALE; MIDDLE AGED; OPIATE ADDICTION;

ADULT; CROSS-SECTIONAL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; LONG QT SYNDROME; MALE; METHADONE; MIDDLE AGED; NARCOTICS; OPIOID-RELATED DISORDERS; YOUNG ADULT;

EID: 84860583025     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2011.03767.x     Document Type: Article

References (22)

1. Martell B. A., Arnsten J. H., Krantz M. J., Gourevitch M. N. Impact of methadone treatment on cardiac repolarization and conduction in opioid users. Am J Cardiol 2005; 95 : 915-18.
2. Krantz M. J., Martin J., Stimmel B., Mehta D., Haigney M. C. QTc interval screening in methadone treatment. Ann Intern Med 2009; 150 : 387-95.
3. Gupta A., Lawrence A. T., Krishnan K., Kavinsky C. J., Trohman R. G. Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes. Am Heart J 2007; 153 : 891-9.
4. Peles E., Bodner G., Kreek M. J., Rados V., Adelson M. Corrected-QT intervals as related to methadone dose and serum level in methadone maintenance treatment (MMT) patients: a cross-sectional study. Addiction 2007; 102 : 289-300.
5. Patel A. M., Singh J. P., Ruskin J. N. Role of implantable cardioverter-defibrillators in patients with methadone-induced long QT syndrome. Am J Cardiol 2008; 101 : 209-11.
6. Sala M., Anguera I., Cervantes M. Torsade de pointes due to methadone. Ann Intern Med 2003; 139 : W64.
7. Viskin S. The QT interval: too long, too short or just right. Heart Rhythm 2009; 6 : 711-15.
8. Al-Khatib S. M., LaPointe N. M., Kramer J. M., Califf R. M. What clinicians should know about the QT interval. JAMA 2003; 289 : 2120-7.
9. Kobza R., Roos M., Niggli B., Abacherli R., Lupi G. A., Frey F. etal. Prevalence of long and short QT in a young population of 41767 predominantly male Swiss conscripts. Heart Rhythm 2009; 6 : 652-7.
10. Wedam E. F., Bigelow G. E., Johnson R. E., Nuzzo P. A., Haigney M. C. QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial. Arch Intern Med 2007; 167 : 2469-75.
11. Cruciani R. A., Sekine R., Homel P., Lussier D., Yap Y., Suzuki Y. etal. Measurement of QTc in patients receiving chronic methadone therapy. J Pain Symptom Manage 2005; 29 : 385-91.
12. Fanoe S., Hvidt C., Ege P., Jensen G. B. Syncope and QT prolongation among patients treated with methadone for heroin dependence in the city of Copenhagen. Heart 2007; 93 : 1051-5.
13. Maremmani I., Pacini M., Cesaroni C., Lovrecic M., Perugi G., Tagliamonte A. QTc interval prolongation in patients on long-term methadone maintenance therapy. Eur Addict Res 2005; 11 : 44-9.
14. Drew B. J., Ackerman M. J., Funk M., Gibler W. B., Kligfield P., Menon V. etal. American Heart Association Acute Cardiac Care Committee of the Council on Clinical C, Council on Cardiovascular N, American College of Cardiology F. Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. J Am Coll Cardiol 2010; 55 : 934-47.
15. Hofman N., Wilde A. A., Kaab S., van Langen I. M., Tanck M. W., Mannens M. M. etal. Diagnostic criteria for congenital long QT syndrome in the era of molecular genetics: do we need a scoring system? Eur Heart J 2007; 28 : 575-80.
16. Anchersen K., Clausen T., Gossop M., Hansteen V., Waal H. Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study. Addiction 2009; 104 : 993-9.
17. Huh B., Park C. H. Retrospective analysis of low-dose methadone and QTc prolongation in chronic pain patients. Korean J Anesthesiol. 2010; 58 : 338-43.
18. Krantz M. J., Kutinsky I. B., Robertson A. D., Mehler P. S. Dose-related effects of methadone on QT prolongation in a series of patients with torsade de pointes. Pharmacotherapy 2003; 23 : 802-5.
19. Ehret G. B., Voide C., Gex-Fabry M., Chabert J., Shah D., Broers B. etal. Drug-induced long QT syndrome in injection drug users receiving methadone: high frequency in hospitalized patients and risk factors. Arch Intern Med 2006; 166 : 1280-7.
20. Ferreira S., Crumb W. J. Jr, Carlton C. G., Clarkson C. W. Effects of cocaine and its major metabolites on the HERG-encoded potassium channel. J Pharmacol Exp Ther 2001; 299 : 220-6.
21. Chakko S., Sepulveda S., Kessler K. M., Sotomayor M. C., Mash D. C., Prineas R. J. etal. Frequency and type of electrocardiographic abnormalities in cocaine abusers (electrocardiogram in cocaine abuse). Am J Cardiol 1994; 74 : 710-3.
22. Fareed A., Vayalapalli S., Byrd-Sellers J., Casarella J., Drexler K., Amar R. etal. Onsite QTc interval screening for patients in methadone maintenance treatment. J Addict Dis 2010; 29 : 15-22.